Table of Contents
Overview
Renal Transplantation: Present Status
Clinical Impact of Nephrotoxicity
Mechanism of Action
RAPAMUNE
mTOR Is a Critical Kinase in Cell Cycle Progression
Rationale for Proposed Indication
RAPAMUNE + CsA Studies 301 + 302 (Integrated Data)
RAPAMUNE as Primary Therapy in De Novo Renal Transplantation
Improved Renal Function in RAPAMUNE Group**
RAPAMUNE Does Not Impair Renal Function in Psoriatic Patients
RAPAMUNE and Renal Function in Clinical Trials
|
Author: Maureen Galie
|